Cargando…

Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatment

The water-soluble glycofullerenes GF1 and GF2 were synthesized using two-step modified Bingel-Hirsch methodology. Interestingly, we identified buckyballs as a novel class of non-receptor Src kinases inhibitors. The evaluated compounds were found to inhibit Fyn A and BTK proteins with IC(50) values i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serda, Maciej, Malarz, Katarzyna, Mrozek-Wilczkiewicz, Anna, Wojtyniak, Marcin, Musioł, Robert, Curley, Steven A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959220/ https://www.ncbi.nlm.nih.gov/pubmed/31937861 http://dx.doi.org/10.1038/s41598-019-57155-7

Ejemplares similares

Interactions of a Water-Soluble Glycofullerene with Glucose Transporter 1. Analysis of the Cellular Effects on a Pancreatic Tumor Model
por: Barańska, Edyta, et al.
Publicado: (2021)

Identification and Biological Evaluation of a Water-Soluble Fullerene Nanomaterial as BTK Kinase Inhibitor
por: Malarz, Katarzyna, et al.
Publicado: (2023)

The role of oxidative stress in activity of anticancer thiosemicarbazones
por: Malarz, Katarzyna, et al.
Publicado: (2018)

Acid selective pro-dye for cellular compartments
por: Czaplińska, Barbara, et al.
Publicado: (2019)

Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles
por: Serda, Maciej, et al.
Publicado: (2022)

Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest
por: Malarz, Katarzyna, et al.
Publicado: (2021)

Iron Chelators and Exogenic Photosensitizers. Synergy through Oxidative Stress Gene Expression
por: Mrozek-Wilczkiewicz, Anna, et al.
Publicado: (2017)

Theoretical and Experimental Investigations of Large Stokes Shift Fluorophores Based on a Quinoline Scaffold
por: Czaplińska, Barbara, et al.
Publicado: (2020)

Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action
por: Mrozek-Wilczkiewicz, Anna, et al.
Publicado: (2015)

Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors
por: Ramos-Soriano, Javier, et al.
Publicado: (2022)

The Landscape of the Anti-Kinase Activity of the IDH1 Inhibitors
por: Malarz, Katarzyna, et al.
Publicado: (2020)

Piperazinyl fragment improves anticancer activity of Triapine
por: Rejmund, Marta, et al.
Publicado: (2018)

In Situ Cellular Localization of Nonfluorescent [60]Fullerene Nanomaterial in MCF-7 Breast Cancer Cells
por: Serda, Maciej, et al.
Publicado: (2022)

Investigation of the Biological Properties of (Hetero)Aromatic Thiosemicarbazones
por: Serda, Maciej, et al.
Publicado: (2012)

Spectroscopic and Biological Properties of the 3-Imino-1,8-naphthalimide Derivatives as Fluorophores for Cellular Imaging
por: Korzec, Mateusz, et al.
Publicado: (2023)

The Effect of Glycerin Content in Sodium Alginate/Poly(vinyl alcohol)-Based Hydrogels for Wound Dressing Application
por: Bialik-Wąs, Katarzyna, et al.
Publicado: (2021)

Influence of the substituent D/A at the 1,2,3-triazole ring on novel terpyridine derivatives: synthesis and properties
por: Zych, Dawid, et al.
Publicado: (2019)

Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations
por: Malarz, Katarzyna, et al.
Publicado: (2023)

Design and synthesis of anticancer 1-hydroxynaphthalene-2-carboxanilides with a p53 independent mechanism of action
por: Spaczyńska, Ewelina, et al.
Publicado: (2019)

An Organic–Inorganic Hybrid Nanocomposite as a Potential New Biological Agent
por: Dulski, Mateusz, et al.
Publicado: (2020)

Glycofullerenes Inhibit Particulate Matter Induced Inflammation and Loss of Barrier Proteins in HaCaT Human Keratinocytes
por: Lee, Chiang-Wen, et al.
Publicado: (2020)

A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
por: Shaurova, Tatiana, et al.
Publicado: (2023)

Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
por: Serda, Maciej, et al.
Publicado: (2014)

Towards water-soluble [60]fullerenes for the delivery of siRNA in a prostate cancer model
por: Korzuch, Julia, et al.
Publicado: (2021)

Author Correction: Towards water-soluble [60]fullerenes for the delivery of siRNA in a prostate cancer model
por: Korzuch, Julia, et al.
Publicado: (2022)

Luminescence and Electrochemical Activity of New Unsymmetrical 3-Imino-1,8-naphthalimide Derivatives
por: Kotowicz, Sonia, et al.
Publicado: (2021)

High pressure as a novel tool for the cationic ROP of γ-butyrolactone
por: Bernat, Roksana, et al.
Publicado: (2021)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

Synthesis of New Styrylquinoline Cellular Dyes, Fluorescent Properties, Cellular Localization and Cytotoxic Behavior
por: Rams-Baron, Marzena, et al.
Publicado: (2015)

A Thiosemicarbazone Derivative as a Booster in Photodynamic Therapy—A Way to Improve the Therapeutic Effect
por: Gawecki, Robert, et al.
Publicado: (2022)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
por: Elechalawar, Chandra Kumar, et al.
Publicado: (2020)

Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019)

A modular approach toward producing nanotherapeutics targeting the innate immune system
por: van Leent, Mandy M. T., et al.
Publicado: (2021)

PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
por: Rosell, Rafael, et al.
Publicado: (2015)

Seeking a better understanding of the non-receptor tyrosine kinase, SRMS
por: Goel, Raghuveera Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_btnf3218rm43drpv9nc1271p21